Yuhsin Kuo

729 total citations
15 papers, 292 citations indexed

About

Yuhsin Kuo is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Yuhsin Kuo has authored 15 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yuhsin Kuo's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Yuhsin Kuo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Yuhsin Kuo collaborates with scholars based in United States, Poland and United Kingdom. Yuhsin Kuo's co-authors include Marilyn E. Morris, Yan Ji, Cuyue Tang, Thomayant Prueksaritanont, Brian Carr, Xiaoyan Chu, Grace Chan, Sarah L. Huszar, Yuexia Liang and Scott D. Kuduk and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Pharmaceutical Research.

In The Last Decade

Yuhsin Kuo

15 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuhsin Kuo United States 9 130 80 78 48 38 15 292
Aiko Fujino Japan 7 75 0.6× 66 0.8× 135 1.7× 17 0.4× 60 1.6× 9 310
Kelly E. Desino United States 9 198 1.5× 57 0.7× 91 1.2× 46 1.0× 48 1.3× 14 465
Christine C. Orozco United States 14 221 1.7× 143 1.8× 75 1.0× 41 0.9× 20 0.5× 20 440
Cathie Xiang United States 13 184 1.4× 152 1.9× 118 1.5× 44 0.9× 42 1.1× 17 572
Adria Colletti United States 13 131 1.0× 90 1.1× 90 1.2× 59 1.2× 20 0.5× 24 372
Angela Wolford United States 10 101 0.8× 156 1.9× 114 1.5× 23 0.5× 32 0.8× 11 375
Charlotte Allerton United States 9 139 1.1× 146 1.8× 143 1.8× 127 2.6× 61 1.6× 13 455
Ian Knemeyer United States 8 163 1.3× 44 0.6× 89 1.1× 23 0.5× 21 0.6× 9 500
R. Battaglia Italy 11 93 0.7× 57 0.7× 71 0.9× 78 1.6× 10 0.3× 26 333

Countries citing papers authored by Yuhsin Kuo

Since Specialization
Citations

This map shows the geographic impact of Yuhsin Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhsin Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhsin Kuo more than expected).

Fields of papers citing papers by Yuhsin Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhsin Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhsin Kuo. The network helps show where Yuhsin Kuo may publish in the future.

Co-authorship network of co-authors of Yuhsin Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhsin Kuo. A scholar is included among the top collaborators of Yuhsin Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhsin Kuo. Yuhsin Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Menzel, Karsten, Yuhsin Kuo, Dapeng Chen, et al.. (2023). Developing a mechanistic understanding of the nonlinear pharmacokinetics of letermovir and prospective drug interaction with everolimus using physiological‐based pharmacokinetic modeling. Clinical and Translational Science. 16(6). 1039–1048. 7 indexed citations
2.
Yee, Ka Lai, Tamara D. Cabalu, Yuhsin Kuo, et al.. (2020). Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin. The Journal of Clinical Pharmacology. 61(3). 394–405. 5 indexed citations
3.
Ma, Bennett, et al.. (2016). Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction. European Journal of Drug Metabolism and Pharmacokinetics. 42(2). 319–326. 4 indexed citations
4.
Layton, M. E., Vadim Dudkin, Michael J. Kelly, et al.. (2016). Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis. Bioorganic & Medicinal Chemistry Letters. 26(4). 1260–1264. 7 indexed citations
5.
Rossi, Michael, Michael J. Kelly, M. E. Layton, et al.. (2016). Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI. ACS Medicinal Chemistry Letters. 7(3). 312–317. 8 indexed citations
6.
Chu, Xiaoyan, Xiaoxin Cai, Donghui Cui, et al.. (2013). In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters. Drug Metabolism and Disposition. 41(3). 668–681. 48 indexed citations
7.
Brnardic, Edward J., Mark E. Fraley, R. M. Garbaccio, et al.. (2010). 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts. Bioorganic & Medicinal Chemistry Letters. 20(10). 3129–3133. 30 indexed citations
8.
Garbaccio, R. M., Edward J. Brnardic, Mark E. Fraley, et al.. (2010). Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor. ACS Medicinal Chemistry Letters. 1(8). 406–410. 14 indexed citations
9.
Tang, Cuyue, Yuhsin Kuo, Nicole T. Pudvah, et al.. (2009). Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys. Biochemical Pharmacology. 78(6). 642–647. 14 indexed citations
10.
11.
Prueksaritanont, Thomayant, et al.. (2006). Rifampin Induces the in Vitro Oxidative Metabolism, but Not the in Vivo Clearance of Diclofenac in Rhesus Monkeys. Drug Metabolism and Disposition. 34(11). 1806–1810. 4 indexed citations
12.
Tang, Cuyue, Yulin Fang, Catherine Booth-Genthe, et al.. (2006). Diclofenac hydroxylation in monkeys: Efficiency, regioselectivity, and response to inhibitors. Biochemical Pharmacology. 73(6). 880–890. 14 indexed citations
13.
Prueksaritanont, Thomayant, Yuhsin Kuo, Cuyue Tang, et al.. (2006). In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies. Drug Metabolism and Disposition. 34(9). 1546–1555. 22 indexed citations
14.
Ji, Yan, Yuhsin Kuo, & Marilyn E. Morris. (2005). Pharmacokinetics of Dietary Phenethyl Isothiocyanate in Rats. Pharmaceutical Research. 22(10). 1658–1666. 87 indexed citations
15.
Tang, Cuyue, Raju Subramanian, Yuhsin Kuo, et al.. (2005). Bioactivation of 2,3-Diaminopyridine-Containing Bradykinin B1 Receptor Antagonists:  Irreversible Binding to Liver Microsomal Proteins and Formation of Glutathione Conjugates. Chemical Research in Toxicology. 18(6). 934–945. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aiko Fujino Breakdown of academic impact, for papers by Kelly E. Desino Breakdown of academic impact, for papers by Christine C. Orozco Breakdown of academic impact, for papers by Cathie Xiang Breakdown of academic impact, for papers by Adria Colletti Breakdown of academic impact, for papers by Angela Wolford Breakdown of academic impact, for papers by Charlotte Allerton Breakdown of academic impact, for papers by Ian Knemeyer Breakdown of academic impact, for papers by R. Battaglia
Rankless by CCL
2026